Concepedia
Statistics
Publications
11
Citations
1.1K
H-Index
10
Active since
2004
Affiliations
Critical Path Institute(Current)
Pfizer (United States)
GlaxoSmithKline (United States)
Eli Lilly (United States)
AbbVie (United States)
Nicholas M. P. King is an author at Critical Path Institute specializing in physiology, cardiac physiology, and pharmacology.
Publications per year
2004–2022
Altered Titin Expression, Myocardial Stiffness, and Left Ventricular Function in Patients With Dilated Cardiomyopathy
Sherif F. Nagueh, Gopi Shah, Yiming Wu et al. · Circulation · 2004 · 486 citations
Medicine, Cardiology, Physiology +14
Candidate biomarkers for the diagnosis and prognosis of drug‐induced liver injury: An international collaborative effort
Rachel J. Church, Gerd A. Kullak‐Ublick, Jiri Aubrecht et al. · Hepatology · 2018 · 243 citations · Full text
Veterinary Medicine, Pharmacology, Toxicology +17
Truncation of Titin’s Elastic PEVK Region Leads to Cardiomyopathy With Diastolic Dysfunction
Henk Granzier, Michaël Radkë, Jun Peng et al. · Circulation Research · 2009 · 112 citations · Full text
Life Sciences, Molecular Biology, Physiology +15
Mouse intact cardiac myocyte mechanics: cross-bridge and titin-based stress in unactivated cells
Nicholas M. P. King, Joshua Nedrud, Nicholas Harrell et al. · The Journal of General Physiology · 2010 · 86 citations · Full text
Natural Sciences, Biophysics, Physiology +17
Serum glutamate dehydrogenase activity enables early detection of liver injury in subjects with underlying muscle impairments
Shelli Schomaker, David M. Potter, Roscoe L. Warner et al. · PLoS ONE · 2020 · 64 citations · Full text
Medicine, Biochemistry, Enzymology +16
1–5 of 11